Permira, a global private equity firm, has appointed David Floyd as a senior advisor to its global healthcare team.

Floyd brings over 35 years of experience in healthcare, including areas such as orthopedics, surgical tools, neurotechnology and spine products. He was group president of orthopedics, Stryker Corp. from 2012 to 2019, where he oversaw a number of acquisitions, most notably Mako Surgical, and also Instratek, Small Bone Innovations and Stanmore Implants. He was previously worldwide president, DePuy Orthopaedics (today, DePuy Synthes, a business of Johnson & Johnson) initially with U.S. responsibility, before being promoted to global responsibility, and also worked at Abbott Laboratories, where his roles included president of spine products. He currently serves as chairman of Corin Group, a tech-enabled orthopedic implant company in which the Permira funds invested in 2018.